Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-22

Clinical Trial Update: A Long-term Moderate Intervention With n-3 LC-PUFA-supplemented Dairy Products in Patients With Rheumatoid Arthritis [NA]

View source ↗

Summary

This update notes the completion of a long-term trial evaluating omega-3 fatty acid-enriched dairy products in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • n-3 LC-PUFA-supplemented dairy products (omega-3 long-chain polyunsaturated fatty acid-enriched dairy products)

Snippet

Sponsor: University of Jena | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED